nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—Lisinopril—dilated cardiomyopathy	0.271	0.532	CbGbCtD
Atazanavir—ABCB1—Spironolactone—dilated cardiomyopathy	0.238	0.468	CbGbCtD
Atazanavir—CYP2C9—cardial valve—dilated cardiomyopathy	0.0218	0.755	CbGeAlD
Atazanavir—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0124	0.0269	CcSEcCtD
Atazanavir—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0118	0.0255	CcSEcCtD
Atazanavir—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.00892	0.0193	CcSEcCtD
Atazanavir—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00869	0.0188	CcSEcCtD
Atazanavir—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00683	0.0148	CcSEcCtD
Atazanavir—Eruption—Furosemide—dilated cardiomyopathy	0.00675	0.0146	CcSEcCtD
Atazanavir—Drug eruption—Furosemide—dilated cardiomyopathy	0.00675	0.0146	CcSEcCtD
Atazanavir—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00634	0.0137	CcSEcCtD
Atazanavir—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00615	0.0133	CcSEcCtD
Atazanavir—Renal pain—Lisinopril—dilated cardiomyopathy	0.00593	0.0128	CcSEcCtD
Atazanavir—Cholestasis—Furosemide—dilated cardiomyopathy	0.00547	0.0118	CcSEcCtD
Atazanavir—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00543	0.0117	CcSEcCtD
Atazanavir—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00524	0.0113	CcSEcCtD
Atazanavir—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00517	0.0112	CcSEcCtD
Atazanavir—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.00512	0.0111	CcSEcCtD
Atazanavir—Gastritis—Spironolactone—dilated cardiomyopathy	0.00491	0.0106	CcSEcCtD
Atazanavir—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00474	0.0103	CcSEcCtD
Atazanavir—Drug interaction—Furosemide—dilated cardiomyopathy	0.00448	0.00969	CcSEcCtD
Atazanavir—Gout—Furosemide—dilated cardiomyopathy	0.00445	0.00962	CcSEcCtD
Atazanavir—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00441	0.00954	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00424	0.00916	CcSEcCtD
Atazanavir—Renal failure—Spironolactone—dilated cardiomyopathy	0.0042	0.00908	CcSEcCtD
Atazanavir—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00385	0.00832	CcSEcCtD
Atazanavir—Urine output increased—Furosemide—dilated cardiomyopathy	0.00376	0.00812	CcSEcCtD
Atazanavir—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00363	0.00784	CcSEcCtD
Atazanavir—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00355	0.00767	CcSEcCtD
Atazanavir—Protein urine present—Lisinopril—dilated cardiomyopathy	0.0035	0.00757	CcSEcCtD
Atazanavir—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00347	0.0075	CcSEcCtD
Atazanavir—Polyuria—Furosemide—dilated cardiomyopathy	0.00343	0.00743	CcSEcCtD
Atazanavir—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00343	0.00743	CcSEcCtD
Atazanavir—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00343	0.00741	CcSEcCtD
Atazanavir—Cough increased—Lisinopril—dilated cardiomyopathy	0.00341	0.00737	CcSEcCtD
Atazanavir—Alopecia—Spironolactone—dilated cardiomyopathy	0.00339	0.00733	CcSEcCtD
Atazanavir—Oliguria—Lisinopril—dilated cardiomyopathy	0.00338	0.00732	CcSEcCtD
Atazanavir—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00337	0.00729	CcSEcCtD
Atazanavir—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00336	0.00727	CcSEcCtD
Atazanavir—Gout—Lisinopril—dilated cardiomyopathy	0.00334	0.00722	CcSEcCtD
Atazanavir—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00316	0.00683	CcSEcCtD
Atazanavir—Purpura—Furosemide—dilated cardiomyopathy	0.00313	0.00677	CcSEcCtD
Atazanavir—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0031	0.0067	CcSEcCtD
Atazanavir—Wheezing—Lisinopril—dilated cardiomyopathy	0.00303	0.00655	CcSEcCtD
Atazanavir—Malaise—Spironolactone—dilated cardiomyopathy	0.00301	0.00651	CcSEcCtD
Atazanavir—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00296	0.0064	CcSEcCtD
Atazanavir—Discomfort—Spironolactone—dilated cardiomyopathy	0.00281	0.00607	CcSEcCtD
Atazanavir—Dehydration—Furosemide—dilated cardiomyopathy	0.0028	0.00607	CcSEcCtD
Atazanavir—Confusional state—Spironolactone—dilated cardiomyopathy	0.00275	0.00594	CcSEcCtD
Atazanavir—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00266	0.00575	CcSEcCtD
Atazanavir—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00262	0.00568	CcSEcCtD
Atazanavir—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00261	0.00565	CcSEcCtD
Atazanavir—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.0026	0.00563	CcSEcCtD
Atazanavir—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00258	0.00558	CcSEcCtD
Atazanavir—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00258	0.00557	CcSEcCtD
Atazanavir—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00256	0.00553	CcSEcCtD
Atazanavir—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00255	0.00552	CcSEcCtD
Atazanavir—Eczema—Lisinopril—dilated cardiomyopathy	0.00252	0.00545	CcSEcCtD
Atazanavir—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00248	0.00537	CcSEcCtD
Atazanavir—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00244	0.00528	CcSEcCtD
Atazanavir—Somnolence—Spironolactone—dilated cardiomyopathy	0.00242	0.00524	CcSEcCtD
Atazanavir—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00241	0.00521	CcSEcCtD
Atazanavir—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00238	0.00515	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00235	0.00509	CcSEcCtD
Atazanavir—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00235	0.00509	CcSEcCtD
Atazanavir—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00232	0.00502	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0023	0.00498	CcSEcCtD
Atazanavir—ABCC1—myocardium—dilated cardiomyopathy	0.00229	0.079	CbGeAlD
Atazanavir—Renal failure—Furosemide—dilated cardiomyopathy	0.00228	0.00494	CcSEcCtD
Atazanavir—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00226	0.00489	CcSEcCtD
Atazanavir—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00225	0.00486	CcSEcCtD
Atazanavir—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00224	0.00486	CcSEcCtD
Atazanavir—Sweating—Furosemide—dilated cardiomyopathy	0.00223	0.00482	CcSEcCtD
Atazanavir—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0022	0.00475	CcSEcCtD
Atazanavir—Urticaria—Spironolactone—dilated cardiomyopathy	0.00216	0.00468	CcSEcCtD
Atazanavir—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00215	0.00466	CcSEcCtD
Atazanavir—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00215	0.00465	CcSEcCtD
Atazanavir—Dehydration—Lisinopril—dilated cardiomyopathy	0.0021	0.00455	CcSEcCtD
Atazanavir—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00206	0.00446	CcSEcCtD
Atazanavir—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00205	0.00442	CcSEcCtD
Atazanavir—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00204	0.00442	CcSEcCtD
Atazanavir—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00202	0.00438	CcSEcCtD
Atazanavir—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00201	0.00434	CcSEcCtD
Atazanavir—Gastritis—Lisinopril—dilated cardiomyopathy	0.002	0.00433	CcSEcCtD
Atazanavir—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00197	0.00427	CcSEcCtD
Atazanavir—Eye disorder—Furosemide—dilated cardiomyopathy	0.00195	0.00422	CcSEcCtD
Atazanavir—Tinnitus—Furosemide—dilated cardiomyopathy	0.00195	0.00421	CcSEcCtD
Atazanavir—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00194	0.00419	CcSEcCtD
Atazanavir—Pruritus—Spironolactone—dilated cardiomyopathy	0.00193	0.00417	CcSEcCtD
Atazanavir—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00192	0.00415	CcSEcCtD
Atazanavir—Angiopathy—Furosemide—dilated cardiomyopathy	0.00189	0.00409	CcSEcCtD
Atazanavir—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00188	0.00408	CcSEcCtD
Atazanavir—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00186	0.00403	CcSEcCtD
Atazanavir—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00183	0.00396	CcSEcCtD
Atazanavir—Malnutrition—Furosemide—dilated cardiomyopathy	0.00182	0.00393	CcSEcCtD
Atazanavir—Dizziness—Spironolactone—dilated cardiomyopathy	0.0018	0.0039	CcSEcCtD
Atazanavir—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.0018	0.0039	CcSEcCtD
Atazanavir—Flatulence—Furosemide—dilated cardiomyopathy	0.00179	0.00387	CcSEcCtD
Atazanavir—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00179	0.00386	CcSEcCtD
Atazanavir—Weight increased—Lisinopril—dilated cardiomyopathy	0.00178	0.00385	CcSEcCtD
Atazanavir—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00178	0.00385	CcSEcCtD
Atazanavir—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00177	0.00383	CcSEcCtD
Atazanavir—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00176	0.00382	CcSEcCtD
Atazanavir—Depression—Lisinopril—dilated cardiomyopathy	0.00174	0.00376	CcSEcCtD
Atazanavir—Vomiting—Spironolactone—dilated cardiomyopathy	0.00173	0.00375	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00173	0.00374	CcSEcCtD
Atazanavir—Rash—Spironolactone—dilated cardiomyopathy	0.00172	0.00372	CcSEcCtD
Atazanavir—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00172	0.00371	CcSEcCtD
Atazanavir—Renal failure—Lisinopril—dilated cardiomyopathy	0.00171	0.00371	CcSEcCtD
Atazanavir—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00171	0.0037	CcSEcCtD
Atazanavir—Headache—Spironolactone—dilated cardiomyopathy	0.00171	0.00369	CcSEcCtD
Atazanavir—Jaundice—Lisinopril—dilated cardiomyopathy	0.0017	0.00368	CcSEcCtD
Atazanavir—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00169	0.00367	CcSEcCtD
Atazanavir—Sweating—Lisinopril—dilated cardiomyopathy	0.00167	0.00362	CcSEcCtD
Atazanavir—Agitation—Furosemide—dilated cardiomyopathy	0.00167	0.00361	CcSEcCtD
Atazanavir—Haematuria—Lisinopril—dilated cardiomyopathy	0.00166	0.0036	CcSEcCtD
Atazanavir—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00165	0.00357	CcSEcCtD
Atazanavir—Nausea—Spironolactone—dilated cardiomyopathy	0.00162	0.0035	CcSEcCtD
Atazanavir—ABCC1—heart—dilated cardiomyopathy	0.0016	0.0551	CbGeAlD
Atazanavir—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00157	0.00339	CcSEcCtD
Atazanavir—Hallucination—Lisinopril—dilated cardiomyopathy	0.00156	0.00337	CcSEcCtD
Atazanavir—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00155	0.00334	CcSEcCtD
Atazanavir—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00154	0.00334	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00154	0.00332	CcSEcCtD
Atazanavir—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00153	0.00332	CcSEcCtD
Atazanavir—Dry mouth—Furosemide—dilated cardiomyopathy	0.00151	0.00327	CcSEcCtD
Atazanavir—Confusional state—Furosemide—dilated cardiomyopathy	0.00149	0.00323	CcSEcCtD
Atazanavir—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00148	0.0032	CcSEcCtD
Atazanavir—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00146	0.00316	CcSEcCtD
Atazanavir—Shock—Furosemide—dilated cardiomyopathy	0.00146	0.00315	CcSEcCtD
Atazanavir—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00145	0.00314	CcSEcCtD
Atazanavir—Skin disorder—Furosemide—dilated cardiomyopathy	0.00144	0.00311	CcSEcCtD
Atazanavir—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00143	0.0031	CcSEcCtD
Atazanavir—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00142	0.00307	CcSEcCtD
Atazanavir—Anorexia—Furosemide—dilated cardiomyopathy	0.00141	0.00306	CcSEcCtD
Atazanavir—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00141	0.00305	CcSEcCtD
Atazanavir—Alopecia—Lisinopril—dilated cardiomyopathy	0.00138	0.00299	CcSEcCtD
Atazanavir—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00137	0.00297	CcSEcCtD
Atazanavir—ABCC1—cardiac atrium—dilated cardiomyopathy	0.00137	0.0472	CbGeAlD
Atazanavir—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00136	0.00295	CcSEcCtD
Atazanavir—Flatulence—Lisinopril—dilated cardiomyopathy	0.00134	0.0029	CcSEcCtD
Atazanavir—Tension—Lisinopril—dilated cardiomyopathy	0.00134	0.00289	CcSEcCtD
Atazanavir—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00133	0.00289	CcSEcCtD
Atazanavir—Nervousness—Lisinopril—dilated cardiomyopathy	0.00132	0.00286	CcSEcCtD
Atazanavir—Back pain—Lisinopril—dilated cardiomyopathy	0.00132	0.00285	CcSEcCtD
Atazanavir—Somnolence—Furosemide—dilated cardiomyopathy	0.00132	0.00285	CcSEcCtD
Atazanavir—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00129	0.00279	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00128	0.00277	CcSEcCtD
Atazanavir—Fatigue—Furosemide—dilated cardiomyopathy	0.00128	0.00276	CcSEcCtD
Atazanavir—Pain—Furosemide—dilated cardiomyopathy	0.00127	0.00274	CcSEcCtD
Atazanavir—Constipation—Furosemide—dilated cardiomyopathy	0.00127	0.00274	CcSEcCtD
Atazanavir—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00126	0.00273	CcSEcCtD
Atazanavir—Angioedema—Lisinopril—dilated cardiomyopathy	0.00125	0.00269	CcSEcCtD
Atazanavir—Malaise—Lisinopril—dilated cardiomyopathy	0.00123	0.00266	CcSEcCtD
Atazanavir—Syncope—Lisinopril—dilated cardiomyopathy	0.00122	0.00264	CcSEcCtD
Atazanavir—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00122	0.00264	CcSEcCtD
Atazanavir—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00121	0.00262	CcSEcCtD
Atazanavir—CYP2C9—heart—dilated cardiomyopathy	0.00121	0.0417	CbGeAlD
Atazanavir—Palpitations—Lisinopril—dilated cardiomyopathy	0.0012	0.0026	CcSEcCtD
Atazanavir—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.0012	0.00259	CcSEcCtD
Atazanavir—Cough—Lisinopril—dilated cardiomyopathy	0.00119	0.00257	CcSEcCtD
Atazanavir—Urticaria—Furosemide—dilated cardiomyopathy	0.00118	0.00255	CcSEcCtD
Atazanavir—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00117	0.00253	CcSEcCtD
Atazanavir—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00117	0.00253	CcSEcCtD
Atazanavir—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00116	0.00251	CcSEcCtD
Atazanavir—Myalgia—Lisinopril—dilated cardiomyopathy	0.00116	0.00251	CcSEcCtD
Atazanavir—Chest pain—Lisinopril—dilated cardiomyopathy	0.00116	0.00251	CcSEcCtD
Atazanavir—Anxiety—Lisinopril—dilated cardiomyopathy	0.00116	0.0025	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00115	0.00249	CcSEcCtD
Atazanavir—Discomfort—Lisinopril—dilated cardiomyopathy	0.00115	0.00248	CcSEcCtD
Atazanavir—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00113	0.00245	CcSEcCtD
Atazanavir—Confusional state—Lisinopril—dilated cardiomyopathy	0.00112	0.00243	CcSEcCtD
Atazanavir—Oedema—Lisinopril—dilated cardiomyopathy	0.00111	0.00241	CcSEcCtD
Atazanavir—Infection—Lisinopril—dilated cardiomyopathy	0.0011	0.00239	CcSEcCtD
Atazanavir—Shock—Lisinopril—dilated cardiomyopathy	0.00109	0.00237	CcSEcCtD
Atazanavir—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00109	0.00236	CcSEcCtD
Atazanavir—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00108	0.00234	CcSEcCtD
Atazanavir—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00108	0.00233	CcSEcCtD
Atazanavir—Asthenia—Furosemide—dilated cardiomyopathy	0.00106	0.0023	CcSEcCtD
Atazanavir—Anorexia—Lisinopril—dilated cardiomyopathy	0.00106	0.00229	CcSEcCtD
Atazanavir—Pruritus—Furosemide—dilated cardiomyopathy	0.00105	0.00227	CcSEcCtD
Atazanavir—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00101	0.00219	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00101	0.00219	CcSEcCtD
Atazanavir—Insomnia—Lisinopril—dilated cardiomyopathy	0.00101	0.00218	CcSEcCtD
Atazanavir—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000992	0.00214	CcSEcCtD
Atazanavir—Somnolence—Lisinopril—dilated cardiomyopathy	0.000989	0.00214	CcSEcCtD
Atazanavir—Dizziness—Furosemide—dilated cardiomyopathy	0.00098	0.00212	CcSEcCtD
Atazanavir—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000979	0.00212	CcSEcCtD
Atazanavir—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000967	0.00209	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00096	0.00208	CcSEcCtD
Atazanavir—Fatigue—Lisinopril—dilated cardiomyopathy	0.000959	0.00207	CcSEcCtD
Atazanavir—Constipation—Lisinopril—dilated cardiomyopathy	0.000951	0.00206	CcSEcCtD
Atazanavir—Pain—Lisinopril—dilated cardiomyopathy	0.000951	0.00206	CcSEcCtD
Atazanavir—Vomiting—Furosemide—dilated cardiomyopathy	0.000942	0.00204	CcSEcCtD
Atazanavir—Rash—Furosemide—dilated cardiomyopathy	0.000935	0.00202	CcSEcCtD
Atazanavir—Dermatitis—Furosemide—dilated cardiomyopathy	0.000934	0.00202	CcSEcCtD
Atazanavir—Headache—Furosemide—dilated cardiomyopathy	0.000929	0.00201	CcSEcCtD
Atazanavir—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000916	0.00198	CcSEcCtD
Atazanavir—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000909	0.00197	CcSEcCtD
Atazanavir—Urticaria—Lisinopril—dilated cardiomyopathy	0.000884	0.00191	CcSEcCtD
Atazanavir—Nausea—Furosemide—dilated cardiomyopathy	0.00088	0.0019	CcSEcCtD
Atazanavir—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000879	0.0019	CcSEcCtD
Atazanavir—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000879	0.0019	CcSEcCtD
Atazanavir—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000819	0.00177	CcSEcCtD
Atazanavir—Asthenia—Lisinopril—dilated cardiomyopathy	0.000798	0.00173	CcSEcCtD
Atazanavir—Pruritus—Lisinopril—dilated cardiomyopathy	0.000787	0.0017	CcSEcCtD
Atazanavir—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000761	0.00165	CcSEcCtD
Atazanavir—Dizziness—Lisinopril—dilated cardiomyopathy	0.000735	0.00159	CcSEcCtD
Atazanavir—Vomiting—Lisinopril—dilated cardiomyopathy	0.000707	0.00153	CcSEcCtD
Atazanavir—Rash—Lisinopril—dilated cardiomyopathy	0.000701	0.00152	CcSEcCtD
Atazanavir—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000701	0.00152	CcSEcCtD
Atazanavir—Headache—Lisinopril—dilated cardiomyopathy	0.000697	0.00151	CcSEcCtD
Atazanavir—Nausea—Lisinopril—dilated cardiomyopathy	0.000661	0.00143	CcSEcCtD
Atazanavir—ABCB1—heart—dilated cardiomyopathy	0.000652	0.0225	CbGeAlD
